Ceribell (CBLL) Cash & Current Investments (2023 - 2026)
Ceribell's (CBLL) quarterly Cash & Current Investments came in at $141.2 million in Q1 2026, down 22.72% YoY from $182.7 million in Q1 2025, and down 11.35% on a QoQ basis from $159.3 million in Q4 2025.
Ceribell (CBLL) Cash & Current Investments (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Cash & Current Investments data on file, last reported at $141.2 million in Q1 2026.
- Quarterly Cash & Current Investments fell 22.72% year-over-year to $141.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $141.2 million (down 22.72% YoY) and the FY2025 annual result came in at $159.3 million, down 18.06% from the prior year.
- Cash & Current Investments eased to $141.2 million in Q1 2026, from $159.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $194.4 million in Q4 2024 to a low of $14.1 million in Q3 2024.
- A 4-year average of $134.0 million and a median of $163.9 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2025 — Cash & Current Investments surged 1095.33% — and 2026, when it slipped 22.72%.
- Tracing CBLL's Cash & Current Investments over 4 years: stood at $34.5 million in 2023, then soared by 463.47% to $194.4 million in 2024, then retreated by 18.06% to $159.3 million in 2025, then declined by 11.35% to $141.2 million in 2026.
- The last three Cash & Current Investments figures came in at $141.2 million (Q1 2026), $159.3 million (Q4 2025), and $168.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Ceribell | 923.61 Mn | 794.35 Mn | 25.94 Mn | 129.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129.26 Mn |
| Mar 31, 2026 | 141.18 Mn |
| Dec 31, 2025 | 159.26 Mn |
| Sep 30, 2025 | 168.54 Mn |
| Jun 30, 2025 | 177.43 Mn |
| Mar 31, 2025 | 182.70 Mn |
| Dec 31, 2024 | 194.37 Mn |
| Sep 30, 2024 | 14.10 Mn |
| Dec 31, 2023 | 34.50 Mn |